Digital Look

Welcome to Digital Look++,
you are not logged in

Creo Medical Group (CREO)

Health Care

11.13p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
30-Jun-25	Interim	2.20	16.10	4.00p	n/a

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	9.43	(23.46)	(12.54)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	25.16	(30.34)	(14.48)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	27.20	(30.90)	(14.48)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	4.00	(26.40)	(8.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	4.00	(29.00)	(8.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	6.06	(0.28)	(3.75)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	10.16	(11.79)	(1.82)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-27	17.67	(5.67)	(0.89)p	n/a	n/a	n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.